Key facts
- The Chinese University of Hong Kong (CUHK) has opened its first cross-border clinical trial centre in Nansha, Guangzhou.
- This initiative is designed to expedite the development and approval processes for new drugs and medical devices.
- The centre will leverage Nansha's strategic location and supportive policies to facilitate clinical research.
The Chinese University of Hong Kong (CUHK) has established its first cross-border clinical trial centre in Nansha, Guangzhou. This new facility is poised to accelerate the development and approval of innovative drugs and medical devices by utilizing Nansha's strategic advantages and favorable policies for clinical research.
The establishment of this centre marks a significant step in fostering cross-border collaboration in medical research and development, aiming to streamline the process from discovery to market availability.